BlueRock Therapeutics
@bluerocktx
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition.
ID: 885301571986243584
http://bluerocktx.com 13-07-2017 00:55:17
359 Tweet
1,1K Followers
155 Following
Poster award prizes at this year’s #MbDsymposium are sponsored by CCRM BlueRock Therapeutics and STEMCELL Technologies. Thanks for your support!
BlueRock Therapeutics Congrats on being named on Comparably's Top 100 list for Best Company Culture in 2021, as rated by your employees. You’re also featured in Business Insider #ComparablyAwards businessinsider.com/small-midsize-…
BlueRock Therapeutics is a Winner of Comparably’s Best Company Culture 2021! Check out our award-winning company culture as rated by our own employees. lnkd.in/gZiWnajs JOIN US! lnkd.in/djDchmVK #BlueRockers #BlueRockTx #culture #community #employerofchoice
BlueRock Therapeutics announced the closeout of the first of two cohorts in our ongoing Phase 1, open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced #parkinsonsdisease. bit.ly/3qW6H8D
BlueRock Therapeutics announced today the dose administration for the first patient in Canada in a Phase 1, open-label trial in patients with advanced #Parkinsons. Read the full release: bit.ly/3GUx99P
You can also watch individual clips featuring Rob Frawley, Lead Community Scientist at BioBus; Rob Coloney, Senior Manager, Talent Acquisition at BlueRock Therapeutics; Shazzia Khan, Global Chief of Staff and Chief Talent Officer at @HavasHealthYou
Congrats! Aino Forsti-Smith, Bayer | Pharmaceuticals Europe; Kim Carson, Yaengsaeng Xayavong, Bayer U.S. 🇺🇸; Stephanie Klocke, Lucy Turland, BD; Joanne Golankiewicz, Stephanie Albanese, Biogen; Ainslie Little, BlueRock Therapeutics ow.ly/VFpS50IiW9b #HBAWOTY22 #HBAimpact #genderequality
We are proud to see Seth Ettenberg CEO of BlueRock Therapeutics, a Leaps company, take the stage at #BreakthroughInnovationForum. Last year, BlueRock announced its first patient dosed for it's Phase 1 trial for Parkinson's disease. What a huge step for #Leap 5 - Protect Brain and Mind.
It was great to hear from Cynata Therapeutics, Amicus Therapeutics, @SernovaCorp, BlueRock Therapeutics, Adaptimmune, OxfordBiomedica, SparingVision, GENETHON France, SiSaf, VectorY, CTI Clinical Trials, & @BoneTherapeutic. #CGMED22!
BlueRock is in Barcelona this week for Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Med! #regenerativemedicine
Yesterday, CEO Seth Ettenberg spoke on a panel at the #WorldMedicalInnovationForum presented by Mass General Brigham. The panel focused on Global Biotech Epicenters, with a focus on New England. youtube.com/clip/UgkxWAtnH… #BlueRockTx #regenerativemedicine #innovation
Great overview of Kendall Square innovation hub via The Boston Globe bostonglobe.com/video/2022/06/…
🗣️ We have a new episode out! Dr. Stefan Irion (Stefan Irion) from BlueRock Therapeutics talks about the company's #ParkinsonsDisease trial, the challenges of genetically manipulating #StemCells, and his journey from physician to scientist! 🎧 Listen now: bit.ly/3ScDJwQ